Top Markets
Coin of the day
Wuhan YZY Biopharma Co Ltd Wuhan YZY Biopharma Co Ltd

Wuhan YZY Biopharma Co Ltd

2496
Rangering i aksjer #22213
Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the... Wuhan YZY Biopharma Co., Ltd. is a biotechnology enterprise specializing in the development of bispecific antibody-based treatments. Its therapeutic focus areas include various cancers, their associated complications, and age-related ophthalmic conditions. The company's extensive portfolio of drug candidates aims to address a wide range of diseases, such as malignant ascites, malignant pleural effusion, various solid tumors (including pancreatic cancer, hepatocellular carcinoma, other advanced solid tumors, and HER2-positive solid tumors), small cell lung cancer, and relapsed/refractory multiple myeloma. Additionally, they are advancing therapies for COVID-19 and several eye disorders like wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and other conditions characterized by abnormal blood vessel formation in the eye. The company, established in 2010, is headquartered in Wuhan, China.
Aksjekurs
$0.46053443
Sist synkronisert: 2026-08-13
Markedsverdi
$92.44M
Endring (1 dag)
0.00%
Endring (1 år)
-36.86%
Land
CN
Handel Wuhan YZY Biopharma Co Ltd (2496)

Kategori

Aksjeprishistorikk for Wuhan YZY Biopharma Co Ltd (2496)
Høyeste sluttskurs: $0.46 den 2026-08-01

Laveste sluttskurs: $2.19 den 2023-09-01
Aksjeprishistorikk for Wuhan YZY Biopharma Co Ltd fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -17.33%
2025 56.85%
2024 -47.06%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH